Cite
HARVARD Citation
Peng, C. et al. (2022). A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off‐therapy relapse: An observational study. Journal of gastroenterology and hepatology. 37 (11), pp. 2164-2172. [Online].